SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001437749-21-003034
Filing Date
2021-02-17
Accepted
2021-02-16 19:43:41
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 dffn20210216_424b5.htm 424B5 534139
2 dffn20200924_s3img001.jpg GRAPHIC 8812
3 dffn20210210_424b5img001.jpg GRAPHIC 8434
  Complete submission text file 0001437749-21-003034.txt   559477
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-249057 | Film No.: 21642008
SIC: 2834 Pharmaceutical Preparations